Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
- PMID: 17521439
- PMCID: PMC1888684
- DOI: 10.1186/1471-244X-7-22
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
Abstract
Background: Schizophrenia is a common psychiatric disease affecting about 1% of population. One major problem in the treatment is finding the right the drug for the right patients. However, pharmacogenetic results in psychiatry can seldom be replicated.
Methods: We selected three candidate genes associated with serotonergic neurotransmission for the study: serotonin 2A (5-HT2A) receptor gene, tryptophan hydroxylase 1 (TPH1) gene, and G-protein beta-3 subunit (GNB3) gene. We recruited 94 schizophrenia patients representing extremes in treatment response to typical neuroleptics: 43 were good responders and 51 were poor responders. The control group consisted of 392 healthy blood donors.
Results: We do, in part, replicate the association between 5-HT2A T102C polymorphism and response to typical neuroleptics. In female patients, C/C genotype was significantly more common in non-responders than in responders [OR = 6.04 (95% Cl 1.67-21.93), p = 0.005] or in the control population [OR = 4.16 (95% CI 1.46-11.84), p = 0.005]. TPH1 A779C C/A genotype was inversely associated with good treatment response when compared with non-responders [OR = 0.59 (95% Cl 0.36-0.98), p = 0.030] or with the controls [OR = 0.44 (95% CI 0.23-0.86, p = 0.016], and GNB3 C825T C/T genotype showed a trend-like positive association among the male patients with a good response compared with non-responders [OR = 3.48 (95% Cl 0.92-13.25), p = 0.061], and a clearer association when compared with the controls [OR = 4.95 (95% CI 1.56-15.70), p = 0.004].
Conclusion: More findings on the consequences of functional polymorphisms for the role of serotonin in the development of brain and serotonergic neurotransmission are needed before more detailed hypotheses regarding susceptibility and outcome in schizophrenia can be formulated. The present results may highlight some of the biological mechanisms in different courses of schizophrenia between men and women.
Similar articles
-
Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.J Psychiatr Res. 2012 Aug;46(8):1073-80. doi: 10.1016/j.jpsychires.2012.04.021. Epub 2012 May 30. J Psychiatr Res. 2012. PMID: 22655589
-
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.J Psychiatry Neurosci. 1999 Mar;24(2):141-6. J Psychiatry Neurosci. 1999. PMID: 10212557 Free PMC article.
-
Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.J Neural Transm (Vienna). 2007;114(4):461-8. doi: 10.1007/s00702-006-0583-6. Epub 2006 Oct 27. J Neural Transm (Vienna). 2007. PMID: 17066254
-
[Pharmacogenetics and treatment response in schizophrenia].Encephale. 2007 Dec;33(6):954-64. doi: 10.1016/j.encep.2007.01.004. Epub 2007 Sep 4. Encephale. 2007. PMID: 18789788 Review. French.
-
[Receptor polymorphism and response to treatment in schizophrenia].Orv Hetil. 2002 Sep 1;143(35):2027-33. Orv Hetil. 2002. PMID: 12387196 Review. Hungarian.
Cited by
-
Association between the rs6313 polymorphism in the 5-HTR2A gene and the efficacy of antipsychotic drugs.BMC Psychiatry. 2023 Sep 19;23(1):682. doi: 10.1186/s12888-023-05165-1. BMC Psychiatry. 2023. PMID: 37726709 Free PMC article.
-
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives.Front Pharmacol. 2022 Oct 12;13:1005702. doi: 10.3389/fphar.2022.1005702. eCollection 2022. Front Pharmacol. 2022. PMID: 36313375 Free PMC article. Review.
-
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.Methods Mol Biol. 2022;2547:389-425. doi: 10.1007/978-1-0716-2573-6_14. Methods Mol Biol. 2022. PMID: 36068471
-
Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.Hum Brain Mapp. 2020 Nov;41(16):4518-4528. doi: 10.1002/hbm.25138. Epub 2020 Jul 22. Hum Brain Mapp. 2020. PMID: 32697408 Free PMC article.
-
Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population.J Mol Neurosci. 2020 Mar;70(3):467-474. doi: 10.1007/s12031-019-01439-0. Epub 2019 Nov 25. J Mol Neurosci. 2020. PMID: 31768945
References
-
- Werkman TR, Glennon JC, Wadman WJ, McCreary AC. Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia. CNS Neurol Disord Drug Targ. 2006;5:3–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
